Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial.
T M L TongM C BurgmansF M SpeetjensA R van ErkelR W van der MeerC S P van RijswijkM A Jonker-BosC F M RoozenM Sporrel-BloklandJ LutjeboerE L van Persijn van MeertenC H MartiniR W M ZoethoutF G J TijlC U BlankE KapiteijnPublished in: Cardiovascular and interventional radiology (2023)
Combining M-PHP with IPI/NIVO was safe in this small cohort of patients with mUM at a dose of IPI 1 mg/kg and NIVO 3 mg/kg.